Edward Berg | Senior Vice President and General Counsel |
Andrei Floroiu | Chief Executive Officer |
James Cummings | Chief Medical Officer |
Sean Tucker | Founder & Chief Scientific Officer |
Phil Lee | Chief Financial Officer |
Mayank Mamtani | B. Riley Securities |
Roger Song | Jefferies |
Greetings and welcome to Vaxart Business Update and First Quarter 2023 Financial Results Conference Call. A question-and-answer session will follow management's opening remarks. Individual investors may submit written questions to ir@vaxart.com.
As a reminder, this conference is being recorded.
I would now like to turn the webcast over to your host, Ed Berg, Senior Vice President and General Counsel.